SEC Form 4 · accession 0001209191-16-114436
Neos Therapeutics, Inc. · NEOS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owners
David J Collier
10% Owner
Presidio Partners 2007, L.P.
10% Owner
James F Watson
10% Owner
Presidio Partners 2007 GP, L.P.
10% Owner
Presidio Partners 2007 GP, LLC
10% Owner
Faysal A. Sohail
10% Owner
Period of report
Apr 13, 2016
Accepted (ET)
Apr 15, 2016 · 5:21 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001467652
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 13, 2016 | S | 12,375 | $10.1619 | D | 1,623,997 | D | |
| Common Stock | Apr 14, 2016 | S | 13,714 | $10.2665 | D | 1,610,283 | D | |
| Common Stock | Apr 14, 2016 | S | 12,675 | $10.3182 | D | 1,597,608 | D | |
| Common Stock | Apr 15, 2016 | S | 10,735 | $10.1255 | D | 1,586,873 | D | |
| Common Stock | Apr 15, 2016 | S | 7,020 | $10.3176 | D | 1,579,853 | D | |
| Common Stock | Apr 13, 2016 | S | 317 | $10.1619 | D | 41,639 | I | by Presidio Partners 2007 (Parallel), L.P |
| Common Stock | Apr 14, 2016 | S | 352 | $10.2665 | D | 41,287 | I | by Presidio Partners 2007 (Parallel), L.P |
| Common Stock | Apr 14, 2016 | S | 325 | $10.3182 | D | 40,962 | I | by Presidio Partners 2007 (Parallel), L.P |
| Common Stock | Apr 15, 2016 | S | 275 | $10.1255 | D | 40,687 | I | by Presidio Partners 2007 (Parallel), L.P |
| Common Stock | Apr 15, 2016 | S | 180 | $10.3176 | D | 40,507 | I | by Presidio Partners 2007 (Parallel), L.P |
Table II — derivative securities
No Table II lines on this filing.